TECHNOLOGY PAGES

 

 

Lung Cancer Fact Sheet

MARKET FOCUS: United States:  According to the Center for Disease Control, there are 94 million past and current smokers in the US; there are 19 million smokers over the age of 45 (the age at which lung cancer incidences increase). Lung cancer claims nearly 200,000 victims each year in the U.S., and is the most common cause of cancer death among men and women. Twenty five percent of Americans smoke, and lung cancer has grown 111% over 30 years. On an average day, 471 Americans are diagnosed with lung cancer, and, of the 471 diagnosed, 420 will die – a dismal 15% survival rate. Early detection could raise the survival rate to approximately 85 percent.

China:  China has approximately 500 million people in a high-risk category. Lung cancer is impacting the labor force – key employees are dying. Treatment costs are high, and the survival rate is below the 15% U.S. survival rate. The World Health Organization has predicted that, of the 300 million young men in the current population in China, 100 million of them will die prematurely as a result of smoking-related illnesses. 

  • Cigarette consumption in China is increasing at the rate of 11% per year.
  • Lung cancer rates in China are increasing by 4.5% per year. By 2025, it is estimated that 2 million Chinese will die from smoking-related illnesses.

Korea:  The Korean market is such that it can be approached immediately, in a very straightforward manner, with minimal overhead costs. Korea currently use the Saccomano method for slide preparation and staining, and has all equipment necessary to begin the TCPP diagnostic process. BioModa has entered into a Marketing and Distribution Agreement with Joseph Trading, Inc. of Korea (JTI) with minimum purchase requirements for BioModa’s proprietary and trade secret protected sample preparation and staining techniques, and TCPP.

Other Potential Markets:  Japan, India, other Pacific Rim countries, Latin America, Africa, and the European Union, represent other potential market opportunities.

LUNG CANCER FACTS:
  • According to the American Cancer Society, lung cancer kills approximately 1 million people worldwide and is the leading cause of cancer deaths in the U.S.
  • Smoking is responsible for nearly 90% of the cancer deaths
  • The incidence of lung cancer continues to rise. It is currently the most fatal cancer malignancy found among men and women in the U.S. and was the most common cause of death in both sexes in 1995 (157,400 deaths).
  • Lung cancer kills women at a rate of 11:1 when compared to the number of women who die from cervical cancer each year.
  • Lung cancer primarily strikes people over age 45, and due to a lack of effective screening, is usually spread by the time that it is diagnosed.
  • Global cigarette production during the past 20 years has increased an average of 2.2% per year.
  • The majority of new cigarette consumers are U.S. minorities such as Hispanics, African-Americans and Native Americans, and people in Third-World developing countries.
LUNG CANCER SYMPTOMS: There are rarely symptoms in the early stages of lung cancer. Advanced stages include coughing, wheezing, hoarseness, chest pain, weight loss, swelling in neck and feet and coughing up blood.
LUNG CANCER TYPES: There are two primary types of lung cancer:
Nonsmall Cell Carcinoma: Includes squamous, adenocarcinoma and large cell carcinoma
Small Cell Carcinoma: Also known as "oat" cell carcinoma, small cell carcinoma accounts for 20% of lung cancer and spreads rapidly.
 
A DIRECT LINK BETWEEN CIGARETTES AND LUNG CANCER: 90% of lung cancer cases are directly linked to smoking. Other risk factors that contribute, particularly in combination with smoking, include exposure to such environmental toxins as radon, asbestos, uranium and heredity. The likelihood of developing lung cancer is directly related to the number of cigarettes smoked over time.
EARLY DETECTION MAKES A DIFFERENCE:
  • Analysis of sputum samples involves a process very similar to that used in pap smears. Other methods for detecting lung cancer include X-ray, sputum analysis, lung biopsy and the use of MRI or CAT scans to locate growths.
  • Only 16% of lung cancer cases are discovered early, yet the difference in five-year survival rates is 46% for cases identified early while the disease is still localized, versus 13% for late-stage cancer diagnosis.
LUNG CANCER TREATMENT:
  • Surgery – To remove portions of the cancerous lung.
  • Radiation – A beam of radiation is aimed directly at the cancer site to destroy the tumor.
  • Chemotherapy – Uses drugs to systematically kill cancer cells throughout the body.
  • Promising Drug Therapies – Two drugs, paclitaxel (Taxol) and vinrelbine (navelbine), look very promising in the treatment of lung cancer, making screening and early detection that much more important.

 

 

 

 

 

Home  ::  About Us  ::  Technology  ::  Links  ::  Contact Us